For more than 20 years, transjugular intrahepatic portosystemic shunts (TIPS) have been used to treat complications of portal hypertension and are now being introduced in an expanding number of clinical settings. The TIPS procedure involves the angiographically guided creation of a connection between the hepatic vein and the intrahepatic portal vein that allows blood to flow from the portal vein to the inferior vena cava and back to systemic circulation with little resistance. The shunt, generally put in place by interventional radiologists, is kept open by the deployment of a metal stent across the tract. The procedure and evidence for its use in specific manifestations of portal hypertension were reviewed in detail in the American Association for the Study of Liver Diseases (AASLD) guidelines [1].
Accepted indications for TIPS are:•
Gastrointestinal BleedingPortal hypertension may lead to gastrointestinal bleeding from a variety of lesions, including varices of the esophagus, stomach, small or large intestine, portal hypertensive gastropathy (PHG), and gastric antral vascular ectasia (GAVE). The role of TIPS in the treatment and prevention of these lesions has not been fully studied in most cases, but about one-third of deaths from cirrhosis are due to gastrointestinal bleeding. TIPS procedures are best studied in this patient population and have been shown to eradicate esophageal varices effectively. The shunts are successful in the treatment of esophageal variceal bleeding that is refractory to firstline endoscopic and pharmacologic therapy, especially in patients who are poor